LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p

Abstract While long noncoding RNAs (lncRNAs) have been reported to play an important role in human cancer types, they remain poorly understood in papillary thyroid carcinoma (PTC). The aim of this study was to use genome-wide expression profiling to identify lncRNAs acting as competing endogenous RN...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kai Guo, Kai Qian, Yuan Shi, Tuanqi Sun, Zhuoying Wang
Formato: article
Lenguaje:EN
Publicado: Nature Publishing Group 2021
Materias:
Acceso en línea:https://doaj.org/article/963ead95d85f47af9270bc53e8c13803
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:963ead95d85f47af9270bc53e8c13803
record_format dspace
spelling oai:doaj.org-article:963ead95d85f47af9270bc53e8c138032021-11-28T12:04:26ZLncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p10.1038/s41419-021-04386-02041-4889https://doaj.org/article/963ead95d85f47af9270bc53e8c138032021-11-01T00:00:00Zhttps://doi.org/10.1038/s41419-021-04386-0https://doaj.org/toc/2041-4889Abstract While long noncoding RNAs (lncRNAs) have been reported to play an important role in human cancer types, they remain poorly understood in papillary thyroid carcinoma (PTC). The aim of this study was to use genome-wide expression profiling to identify lncRNAs acting as competing endogenous RNAs (ceRNAs) in PTC. We constructed a ceRNA network based on our lncRNA microarray data and validated the correlation between myocardial infarction-associated transcript lncRNA (MIAT), miRNA-150-5p, and EZH2 in vitro and in vivo. We found 15 lncRNAs, 28 miRNAs, and hundreds of mRNAs involved in this ceRNA network. Splendid positive correlations were found between the MIAT and EZH2 expression in types of cancer in TCGA data. Besides, significant differences in MIAT/EZH2 expression were found among various clinicopathological features. Gain- and loss-of-function experiments revealed that MIAT inhibited cell proliferation and migration in vitro. Moreover, EZH2 was identified as a direct downstream target of miR-150-5p in PTC cells. Restoration of EZH2 expression partially abolished the biological effects of miR-150-5p. Furthermore, overexpression of MIAT was inversely correlated with miR-150-5p expression. Knockdown of MIAT produced significant behavioral alter maybe partly due to the function of the MIAT-150-5p-EZH2 network. Our findings suggest MIAT may inhibit EZH2 expression and promote PTC cell invasion via the miR-150/EZH2 pathway. Therefore, MIAT may serve as a valuable prognostic biomarker and therapeutic target for PTC.Kai GuoKai QianYuan ShiTuanqi SunZhuoying WangNature Publishing GrouparticleCytologyQH573-671ENCell Death and Disease, Vol 12, Iss 12, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Cytology
QH573-671
spellingShingle Cytology
QH573-671
Kai Guo
Kai Qian
Yuan Shi
Tuanqi Sun
Zhuoying Wang
LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p
description Abstract While long noncoding RNAs (lncRNAs) have been reported to play an important role in human cancer types, they remain poorly understood in papillary thyroid carcinoma (PTC). The aim of this study was to use genome-wide expression profiling to identify lncRNAs acting as competing endogenous RNAs (ceRNAs) in PTC. We constructed a ceRNA network based on our lncRNA microarray data and validated the correlation between myocardial infarction-associated transcript lncRNA (MIAT), miRNA-150-5p, and EZH2 in vitro and in vivo. We found 15 lncRNAs, 28 miRNAs, and hundreds of mRNAs involved in this ceRNA network. Splendid positive correlations were found between the MIAT and EZH2 expression in types of cancer in TCGA data. Besides, significant differences in MIAT/EZH2 expression were found among various clinicopathological features. Gain- and loss-of-function experiments revealed that MIAT inhibited cell proliferation and migration in vitro. Moreover, EZH2 was identified as a direct downstream target of miR-150-5p in PTC cells. Restoration of EZH2 expression partially abolished the biological effects of miR-150-5p. Furthermore, overexpression of MIAT was inversely correlated with miR-150-5p expression. Knockdown of MIAT produced significant behavioral alter maybe partly due to the function of the MIAT-150-5p-EZH2 network. Our findings suggest MIAT may inhibit EZH2 expression and promote PTC cell invasion via the miR-150/EZH2 pathway. Therefore, MIAT may serve as a valuable prognostic biomarker and therapeutic target for PTC.
format article
author Kai Guo
Kai Qian
Yuan Shi
Tuanqi Sun
Zhuoying Wang
author_facet Kai Guo
Kai Qian
Yuan Shi
Tuanqi Sun
Zhuoying Wang
author_sort Kai Guo
title LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p
title_short LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p
title_full LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p
title_fullStr LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p
title_full_unstemmed LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p
title_sort lncrna-miat promotes thyroid cancer progression and function as cerna to target ezh2 by sponging mir-150-5p
publisher Nature Publishing Group
publishDate 2021
url https://doaj.org/article/963ead95d85f47af9270bc53e8c13803
work_keys_str_mv AT kaiguo lncrnamiatpromotesthyroidcancerprogressionandfunctionascernatotargetezh2byspongingmir1505p
AT kaiqian lncrnamiatpromotesthyroidcancerprogressionandfunctionascernatotargetezh2byspongingmir1505p
AT yuanshi lncrnamiatpromotesthyroidcancerprogressionandfunctionascernatotargetezh2byspongingmir1505p
AT tuanqisun lncrnamiatpromotesthyroidcancerprogressionandfunctionascernatotargetezh2byspongingmir1505p
AT zhuoyingwang lncrnamiatpromotesthyroidcancerprogressionandfunctionascernatotargetezh2byspongingmir1505p
_version_ 1718408214124429312